HAO vs AIXI

For growth investors, Haoxi Health Technology Limited (HAO) is the stronger pick with 71.

9% revenue growth year-over-year, versus 18. 8% for Xiao-I Corporation (AIXI). Haoxi Health Technology Limited (HAO) offers the better valuation at 0. 7x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Xiao-I Corporation (AIXI) delivered a total return of -98.

6%, compared to -99. 5% for Haoxi Health Technology Limited (HAO). Over 10 years, the gap is even starker: HAO returned -96. 7% versus AIXI's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Haoxi Health Technology Limited (HAO) is the lower-risk stock at 0.

65β versus Xiao-I Corporation's 0. 94β — meaning AIXI is approximately 46% more volatile than HAO relative to the S&P 500.

By revenue growth (latest reported year), Haoxi Health Technology Limited (HAO) is pulling ahead at 71.

9% versus 18. 8% for Xiao-I Corporation (AIXI). On earnings-per-share growth, the picture is similar: Haoxi Health Technology Limited grew EPS 1105% year-over-year, compared to 52. 7% for Xiao-I Corporation. Over a 3-year CAGR, HAO leads at 55. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Haoxi Health Technology Limited (HAO) is the more profitable company, earning 2.

7% net margin versus -20. 6% for Xiao-I Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HAO leads at 3. 5% versus -18. 3% for AIXI. At the gross margin level — before operating expenses — AIXI leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Haoxi Health Technology Limited (HAO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

65)). Both have compounded well over 10 years (HAO: -96. 7%, AIXI: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HAO (Communication Services) and AIXI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.